πŸ‡ΊπŸ‡Έ FDA
Patent

US 9889230

Hemostatic implant

granted A61PA61P17/02A61P19/00

Quick answer

US patent 9889230 (Hemostatic implant) held by Covidien LP expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Covidien LP
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P17/02, A61P19/00